Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,721.70
(
0.33%
)
US TECH 100
24,126.54
(
0.46%
)
Dow Jones
47,071.06
(
0.27%
)
Brent Oil
99.74
(
1.46%
)
Bitcoin
74,164.07
(
-0.91%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: DewDiligence post# 123920

Tuesday, 07/26/2011 9:14:21 AM

Tuesday, July 26, 2011 9:14:21 AM

Post# of 257251
The trend in global Tysabri sales is what interests Elan investors.

>•Global in-market sales of TYSABRI in the second quarter of 2011 were $389 million, an increase of 31% over the second quarter of 2010. The total was comprised of $183 million in U.S. sales and $206 million in sales to markets outside the U.S.<

http://pharmalive.com/News/Index.cfm?articleid=795515

Would I be correct in saying Tysabri is picking up some steam?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now